Device Trial Radar · NCT01325623
Seizure Detection and Automatic Magnet Mode Performance Study
Last checked: Nov 20, 2026Latest source record: Jan 22, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
31
Actual
Start
Mar 2011
Primary completion
Jul 2013
Study completion Jul 2015
Sponsor
- Lead sponsor
- Cyberonics, Inc.Public (LIVN)
- Sponsor type
- Industry
- Collaborators
- PRA Health Sciences
- First posted
- Mar 30, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to confirm cardiac-based seizure detection in Cyberonics Model 106 VNS Therapy System.
Conditions
- Epilepsy
Interventions
Model 106 VNS Therapy SystemDevice
The VNS Therapy System is an adjunctive therapy for the treatment of epilepsy. VNS Therapy is available as a scheduled stimulation, this is cyclic stimulation between programmable On- and Off- times (e.g., a 30-second burst every 5 minutes). VNS Therapy is also available as on-demand stimulation, that is, when a magnet is introduced briefly over the implanted device (Magnet Mode). The AspireSR VNS Therapy System includes a new feature, Automatic Magnet Mode or AutoStim. In addition to Normal Mode and Magnet Mode, AspireSR uses a Seizure Detection Algorithm to identify a potential seizure onset based on associated heart rate increases known as ictal tachycardia. The purpose is to deliver stimulation at or near the onset of a seizure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Summary of Seizures Reported by Investigators and Triple ReviewTime frame: Epilepsy Monitoring Unit Stay
- Observed Sensitivity Based on Heart Rate Increase Associated With Seizures by Randomized SDA SettingTime frame: Epilepsy Monitoring Unit (EMU) Stay
- Modeled Sensitivity Based on Heart Rate Increase Associated With Seizures by SDA Setting Post-Processed Through Bench-top Device SimulantTime frame: Epilepsy Monitoring Unit (EMU) Stay
1 more outcomes with a free account
Locations
14 sites in 5 countries. Site status is shown where the registry gives one.
Hôpital Erasme
Anderlecht, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.